AAPL 192.14 -3.2 (-1.64%)MSFT 117.58 -2.46 (-2.05%)FB 164.73 -1.32 (-0.79%)ZNGA 5.3 -0.13 (-2.31%)NVDA 177.26 -6.63 (-3.61%)WBA 62.56 -1.01 (-1.59%)GOOG 1205.94 -25.16 (-2.04%)PIH 5.45 -0.16 (-2.85%)
AAPL 192.14 -3.2 (-1.64%)MSFT 117.58 -2.46 (-2.05%)FB 164.73 -1.32 (-0.79%)ZNGA 5.3 -0.13 (-2.31%)NVDA 177.26 -6.63 (-3.61%)WBA 62.56 -1.01 (-1.59%)GOOG 1205.94 -25.16 (-2.04%)PIH 5.45 -0.16 (-2.85%)

Discounted Cash Flow (DCF) Analysis Unlevered

InflaRx N.V. Quote

InflaRx N.V. (IFRX)

43.22 -2.29 Healthcare
All | Operating Data | Balance Sheet Data | Weighted Average Cost Of Capital | Build Up Free Cash | Terminal Value | Intrinsic Value | Results

Operating Data IFRX Quote InflaRx N.V

Balance Sheet Data IFRX Quote InflaRx N.V

Weighted Average Cost Of Capital IFRX Quote InflaRx N.V

Share Price $ 43.22
Diluted Shares Outstanding 23
Cost of Debt
Tax Rate -
After-tax Cost of Debt -
Risk Free Rate
Market Risk Premium
Cost of Equity 2.18
Total Debt 0.00
Total Equity 388.98
Total Capital 388.98
Debt Weighting 0.00
Equity Weighting 100.00
Wacc

Build Up Free Cash IFRX Quote InflaRx N.V

Terminal Value IFRX Quote InflaRx N.V

Growth in perpetuity method:
Long term growth rate
WACC (%) 2.2
Free cash flow (t+1) 0.00
Terminal Value 0.00
Present Value of Terminal Value 0.00

Intrinsic Value IFRX Quote InflaRx N.V

Enterprise Value -
Net Debt -123
Equity Value -
Shares Outstanding 9
Equity Value Per Share -

Results Unlevered DCF IFRX Quote InflaRx N.V